Arbutus and Genevant's complaint claimed that Moderna's mRNA-based Spikevax shot used lipid nanoparticle (LNP) delivery ...

The study analysed two years of search ads linked to Ozempic.com. An estimated $7.5m was spent on 15,000+ keywords, ...

The latest phase of the long-running scheme – run by Cancer Research UK (CRUK) and the National Cancer Institute (NCI) in the ...

Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in ...

The UK government is providing nearly £50 million in funding for equipment that it says will help the NHS carry out ...

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now, it’s possible to connect your data and tool ecosystem. There is a gold rush happening in ...

The FDA announced a concerted action against direct-to-consumer (DTC) advertising of pharma products last September, and has since sent thousands of letters warning pharmaceutical and telehealth firms ...

McKinnon discusses ‘white space’ in R&D, about integrating generative and agentic AI with human-in-the-loop oversight while prioritising patient safety and regulatory, and how all this advances health ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Atrium is led by Kathleen Gallagher, who was chief programme officer at Avidity before it was acquired by Novartis and will ...

The Centers for Medicare & Medicaid Services (CMS) in the US has extended the deadline for companies to take part in its ...

The approval gives Ascendis a window of opportunity to eat into BioMarin's market share, as the latter works on its own ...